[ad_1]
WellTheory, a digital well being firm for autoimmune illness, introduced on Tuesday that it has raised $14 million in Sequence A funding, which is able to assist the corporate scale and advance its AI.
Atherton, California-based WellTheory treats autoimmune situations resembling Addison’s illness, celiac illness, a number of sclerosis and lupus. Utilizing a collaborative care mannequin, it companions with sufferers’ physicians to ship personalised plans targeted on vitamin, stress, sleep and motion. The corporate provides video periods, limitless skilled messaging and diagnostics. It serves each employers and well being plans.
The Sequence A spherical was led by Basic Catalyst and included participation from 7wireVentures, Ingeborg Investments, Accel, Field Group, Leaps by Bayer and Up2 Alternative Fund. In whole, WellTheory has raised $26.2 million.
“WellTheory is addressing the influence of autoimmune illness by recognizing the essential position that weight loss plan and way of life can play in supporting sufferers. The platform is demonstrating how this sort of help could be delivered at scale, and that is just the start. It’s increasing to combine medical therapy and medicine administration, making a extra complete mannequin designed to enhance affected person experiences and strengthen system sustainability,” stated Candace Richardson, accomplice at Basic Catalyst, in a press release. Richardson is becoming a member of WellTheory’s board.
The financing will assist increase Welltheory’s partnerships with new and current prospects, in keeping with Ellen Rudolph, CEO and co-founder of WellTheory.
“We’ll be increasing our applications for among the most expensive autoimmune situations and accelerating the event of our AI capabilities,” she added in an e mail. “These efforts will assist us ship whole-person autoimmune care at scale — enhancing high quality of life for our members whereas driving vital value financial savings for our companions.”
Since launching within the business market about 18 months in the past, WellTheory has secured a number of main employer purchasers, together with Dayforce, Fortune Manufacturers Improvements and Maven Clinic. It additionally introduced in June that it’s working with Sentara Well being Plans.
The funding announcement comes at a time when greater than 50 million Individuals battle autoimmune situations, together with rheumatoid arthritis, lupus and a number of sclerosis. The autoimmune therapy market is increasing quickly, valued at greater than $166 billion in 2024.
WellTheory finally goals to scale to fulfill this demand, in keeping with Rudolph.
“We’re getting into our subsequent section of development, targeted on increasing entry to our mannequin by means of new employer and payor partnerships, investing in AI that allows extra exact and compassionate care, and persevering with to construct proof for our outcomes. … Our north star stays the identical: making high-quality, whole-person take care of autoimmune illness accessible, inexpensive, and sustainable for sufferers and the healthcare system alike,” she stated.
Image: Feodora Chiosea, Getty Photos
[ad_2]
